Descriptions

The autoinhibited protein was predicted that may have potential autoinhibitory elements via cis-regPred.

Autoinhibitory domains (AIDs)

Target domain

Relief mechanism

Assay

cis-regPred

Accessory elements

No accessory elements

Autoinhibited structure

Activated structure

1 structures for Q9C9U3

Entry ID Method Resolution Chain Position Source
AF-Q9C9U3-F1 Predicted AlphaFoldDB

28 variants for Q9C9U3

Variant ID(s) Position Change Description Diseaes Association Provenance
ENSVATH01532492 6 S>F No 1000Genomes
tmp_1_27707390_A_C 10 F>V No 1000Genomes
ENSVATH05140329 19 V>I No 1000Genomes
ENSVATH01532487 52 A>T No 1000Genomes
ENSVATH14477098 71 P>S No 1000Genomes
ENSVATH05140319 78 D>N No 1000Genomes
ENSVATH01532485 113 S>A No 1000Genomes
ENSVATH13803878 116 Q>L No 1000Genomes
ENSVATH00141582 125 S>T No 1000Genomes
tmp_1_27706285_G_C 133 A>G No 1000Genomes
tmp_1_27705772_C_T 240 G>R No 1000Genomes
tmp_1_27705766_C_T 242 G>S No 1000Genomes
ENSVATH14477079 286 Y>C No 1000Genomes
ENSVATH05140281 287 P>Q No 1000Genomes
ENSVATH13803862 389 I>L No 1000Genomes
ENSVATH01532463 394 N>I No 1000Genomes
ENSVATH05140279 394 N>K No 1000Genomes
ENSVATH01532463 394 N>S No 1000Genomes
ENSVATH05140278 401 E>D No 1000Genomes
tmp_1_27705050_T_G 409 I>L No 1000Genomes
ENSVATH05140271 423 A>G No 1000Genomes
ENSVATH05140270 426 L>I No 1000Genomes
ENSVATH14477076 450 N>I No 1000Genomes
ENSVATH00141578 469 I>M No 1000Genomes
ENSVATH01532459 483 G>R No 1000Genomes
tmp_1_27704417_G_A 567 T>M No 1000Genomes
ENSVATH05140263 592 I>V No 1000Genomes
ENSVATH00141565 598 R>K No 1000Genomes

No associated diseases with Q9C9U3

1 regional properties for Q9C9U3

Type Name Position InterPro Accession
domain AP2/ERF domain 26 - 90 IPR001471

Functions

Description
EC Number
Subcellular Localization
PANTHER Family
PANTHER Subfamily
PANTHER Protein Class
PANTHER Pathway Category No pathway information available

No GO annotations of cellular component

Name Definition
No GO annotations for cellular component

5 GO annotations of molecular function

Name Definition
dioxygenase activity Catalysis of an oxidation-reduction (redox) reaction in which both atoms of oxygen from one molecule of O2 are incorporated into the (reduced) product(s) of the reaction. The two atoms of oxygen may be distributed between two different products. [DOI:10.1016/S0040-4020(03)00944-X, GOC:bf]
heme binding Binding to a heme, a compound composed of iron complexed in a porphyrin (tetrapyrrole) ring.
metal ion binding Binding to a metal ion.
oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen Catalysis of an oxidation-reduction (redox) reaction in which hydrogen or electrons are transferred from one donor, and two oxygen atoms is incorporated into a donor.
peroxidase activity Catalysis of the reaction: a donor + a peroxide = an oxidized donor + 2 H2O.

6 GO annotations of biological process

Name Definition
fatty acid biosynthetic process The chemical reactions and pathways resulting in the formation of a fatty acid, any of the aliphatic monocarboxylic acids that can be liberated by hydrolysis from naturally occurring fats and oils. Fatty acids are predominantly straight-chain acids of 4 to 24 carbon atoms, which may be saturated or unsaturated; branched fatty acids and hydroxy fatty acids also occur, and very long chain acids of over 30 carbons are found in waxes.
fatty acid metabolic process The chemical reactions and pathways involving fatty acids, aliphatic monocarboxylic acids liberated from naturally occurring fats and oils by hydrolysis.
leaf senescence The last stage of leaf development during which programmed degradation of macromolecules and nutrient recycling take place.
long-chain fatty acid metabolic process The chemical reactions and pathways involving long-chain fatty acids, A long-chain fatty acid is a fatty acid with a chain length between C13 and C22.
oxylipin biosynthetic process The chemical reactions and pathways resulting in the formation of any oxylipin, any of a group of biologically active compounds formed by oxidative metabolism of polyunsaturated fatty acids.
response to oxidative stress Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of oxidative stress, a state often resulting from exposure to high levels of reactive oxygen species, e.g. superoxide anions, hydrogen peroxide (H2O2), and hydroxyl radicals.

7 homologous proteins in AiPD

UniProt AC Gene Name Protein Name Species Evidence Code
O62664 PTGS1 Prostaglandin G/H synthase 1 Bos taurus (Bovine) PR
Q8HZR1 PTGS1 Prostaglandin G/H synthase 1 Canis lupus familiaris (Dog) (Canis familiaris) PR
Q9UPX0 IGSF9B Protein turtle homolog B Homo sapiens (Human) PR
P35354 PTGS2 Prostaglandin G/H synthase 2 Homo sapiens (Human) PR
P23219 PTGS1 Prostaglandin G/H synthase 1 Homo sapiens (Human) PR
P22437 Ptgs1 Prostaglandin G/H synthase 1 Mus musculus (Mouse) PR
Q05769 Ptgs2 Prostaglandin G/H synthase 2 Mus musculus (Mouse) PR
10 20 30 40 50 60
MGFSPSSSWF LHPQLHHVVS KMSYFDAFLF YIVHLVDKLG LWHRFPVLLG VAYLGLRRHL
70 80 90 100 110 120
HQRYNLVHVG PINGQGYDTD EFCYRTADGK CNHPSDNTIG SQGSFIGRNM PPSTSQYGIL
130 140 150 160 170 180
DPHPSVVATK LLARKRFIDN GDQFNVIACS WIQFMIHDWV DHLEDTHQIE LEAPEEVASG
190 200 210 220 230 240
CPLKSFKFLR TKKVPTDDHH KSGAVNTRTP WWDGSVIYGN DETGMRRVRV FKDGKLKISG
250 260 270 280 290 300
DGLLERDERG VPISGDIRNS WSGFSLLQAL FVKEHNSVCD MLKERYPDFD DEKLYRTARL
310 320 330 340 350 360
VTAAVIAKVH TIDWTIELLK TDTLTAGMRI NWYGFFGKKV KDMVGARFGP LFSGLVGLKK
370 380 390 400 410 420
PNDHGVPYSL TEEFVSVYRM HCLLPETLIL RDMNSENVDK ENPAIEREIP MTELIGKKAG
430 440 450 460 470 480
EKASKLGFEQ LLVSMGHQSC GALTLWNYPN WMRNLVAQDI DGEDRPHLID MAALEIYRDR
490 500 510 520 530 540
ERGVPRYNEF RKNLLMSPIS KWEELTDDEE AIKVLREVYE DDIEKLDLNV GLHAEKKIKG
550 560 570 580 590 600
FAISETAFFI FLLVASRRLE ADRFFTTNFN EKTYTKEGLE WVNTTETLKD VIDRHFPRLT
610 620 630
DQWMRCSSAF SVWGSDPNPK NWVPLYLRSA P